Skip to main content
OpenTrials

Clinical trial condition

Retinal Degeneration

Explore clinical trials studying Retinal Degeneration. Study availability and eligibility vary by location and protocol.

1,390 public trials 173 recruiting studies
Refine in advanced search Browse all conditions

Retinal Degeneration trial results

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

NCT04740931

Conditions
Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +10 more
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 194 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

NCT04740905

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +9 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
  • Retinal Diagnostic Center Campbell, California, United States
  • The Retina Partners Encino, California, United States
View all 150 locations
View Trial Details
Completed

VISUPRIME® Eye Drops

NCT05677685

Conditions
Diabetic Macular Edema, Disease, Eye Diseases, +9 more
Locations
  • Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari, BA, Italy
  • Ospedale Santa Maria della Misericordia Perugia, PG, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS Rome, RM, Italy
  • Azienda Sanitaria Universitaria Giuliano Isontina Trieste, TS, Italy
View Trial Details
Completed

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

NCT04604899

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Gavin Herbert Eye Inst, Univ Cal Irvine Irvine, California, United States
  • Retina-Vitreous Associates Medical Group Los Angeles, California, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
View Trial Details
Completed

Geographic Atrophy Long-Terms Outcomes Study

NCT06499571

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Sydney West Retina Westmead, New South Wales, Australia
  • Centre Hospitalier de la Croix Rousse Lyon, Rhone, France
  • Universitaetsklinikum Muenster Münster, North Rhine-Westphalia, Germany
  • Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco) Milan, Italy
View Trial Details
Completed

ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA

NCT03891875

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Associated Retina Consultants, Ltd. Peoria, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Arizona Retina & Vitreous Consultants Phoenix, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
View all 37 locations
View Trial Details
Completed

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

NCT03927690

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +22 more
Locations
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Rancho Cordova, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site ‘Aiea, Hawaii, United States
View all 22 locations
View Trial Details

Related conditions